IP Library Granted Patent US 6,906,031
Granted Patent B2
US 6,906,031 · App. 10/877,751 · Granted Jun 14, 2005

Polyacid glycopeptide derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,906,031
App. No.
10/877,751
Granted
Jun 14, 2005
Kind
B2
Abstract

Disclosed are derivatives of glycopeptides that are substituted at the C-terminus with a substituent that comprises two or more (e.g. 2, 3, 4, or 5) carboxy (CO 2 H) groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.

Claims (11)

1. A compound of formula II:

wherein

R a is —CH 2 CH 2 —, —CH 2 CH 2 CH 2 — or —CH 2 CH 2 CH 2 CH 2 —;

R b and Z form an n-octyl, n-nonyl, n-decyl, n-undecyl or n-dodecyl group;

or a pharmaceutically acceptable salt or stereoisomer thereof.

2. The compound of claim 1 , wherein R a is —CH 2 CH 2 —.

3. The compound of claim 2 , wherein R b and Z form an n-decyl group.

4. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound of any one of claims 1 , 2 or 3 .

5. The pharmaceutical composition of claim 4 , wherein the composition further comprises a cyclodextrin.

6. The pharmaceutical composition of claim 5 , wherein the cyclodextrin is hydroxypropyl-β-cyclodextrin or sulfobutyl ether β-cyclodextrin.

7. A method of treating a bacterial disease in a mammal, the method comprising administering to the mammal a therapeutically effective amount of a compound of any one of claims 1 , 2 or 3 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033162/0891 →